Diskussionsleitung: K. Kettering (Frankfurt am Main), A. Maier (Freiburg im Breisgau)
| (P1219) | Parameters for mechanical dyssynchrony on echocardiography: New equals better? | |
| J. Duchenne, A. Puvrez, O. Mirea, S. Bézy, L. Wouters, A. Beela, E. Donal, J.-U. Voigt (Leuven, BE; Craiova, RO; Maastricht, NL; Rennes, FR) | ||
| (P1217) | Cardiac Magnetic Resonance Imaging and Performance of the Updated Lake Louise Criteria in the Detection of Immune Checkpoint Inhibitor-associated Myocarditis. | |
| L. D. Weberling, D. Finke, M. Heckmann, N. Frey, F. André, L. H. Lehmann (Heidelberg) | ||
| (P1218) | Cardiac magnetic resonance based left atrial function and 3D scar is closely linked to low voltage zones in patients with atrial fibrillation | |
| L. Pu, M. Wagner, J. Tomala, Y. Huo, U. Richter, J. Mayer, A. M. Zedda, B. Kirstein, A. Haferkorn, C. Piorkowski, T. Gaspar, S. Ulbrich, für die Studiengruppe: AFMRI (Dresden, Lübeck, Eschborn) | ||
| (P1220) | Feasibility and image quality of myocardial (stress-) perfusion imaging by cardiovascular magnetic resonance in patients with active cardiac implantable electronic devices | |
| C. Meier, M. Bietenbeck, B. Chamling, V. Vehof, P. Stalling, M. Weil, A. Yilmaz, S. Drakos (Münster) | ||
| (P1221) | Comparison of Machine-Learning Computed Tomography-based Fractional Flow Reserve and Stress Perfusion Cardiovascular Magnetic Resonance Imaging to Detect Myocardial Ischemia | |
| S. Klenantz, D. Loßnitzer, F. André, J. Görich, J. Schöpf, K. Pazzo, A. Sommer, M. Brado, F. Gückel, R. Sokiranski, T. Becher, I. Akin, S. Buß, S. Baumann (Mannheim, Heidelberg, Sinsheim; Charleston, US) | ||
| (P1222) | Real-time CMR Imaging for Non-Invasive Characterisation of HFpEF: Medium-Term Outcomes of the HFpEF Stress Trial | |
| S. J. Backhaus, S. Rösel, A. Schulz, T. Lange, K. Hellenkamp, R. Gertz, R. Wachter, M. Steinmetz, S. Kutty, U. Raaz, T. Friede, T. Seidler, M. Uecker, G. Hasenfuß, A. Schuster (Göttingen, Köln, Leipzig; Baltimore, US; Graz, AT) | ||
| (P1223) | Increased aortic stiffness and vascular inflammation in myocardial dysfunction in Long COVID-19 disease. | |
| E. Giokoglu, S. Martin, B. Vanchin, N. Holm, C. Arendt, A. Karyou, A. M. Zeiher, E. Nagel, V. Puntmann (Frankfurt am Main) |
